SCHEMBL23097308

SCHEMBL23097308

CC1(C)c2ccccc2-c2ccc(N(c3ccc(-c4ccc(N(c5ccc(-c6ccccc6)cc5)c5ccc(-c6ccccc6)cc5)cc4)cc3)c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
OPRK1 P41145 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PDK2 Q15119 5/20 0.35
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
MLNR O43193 1/20 0.30
NR1I2 O75469 1/20 0.30
CHRM2 P08172 1/20 0.30
ADRB1 P08588 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
CHRM1 P11229 1/20 0.30
DRD2 P14416 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21969203 1.00 KDM4E (0.36) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL16996074 1.00 KDM4E (0.36) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL16996075 1.00 KDM4E (0.36) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL21559166 0.97 PDK2 (0.34) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL16996192 0.97 PDK2 (0.34) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL25850904 0.97 MEN1 (0.37) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL16996283 0.97 PDK2 (0.39) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL21968817 0.97 PDK2 (0.39) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL17033064 0.97 PDK2 (0.39) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL16996290 0.97 PDK2 (0.39) KDM4EMEN1LMNAMAPTOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3792259-B1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECH CO LTD (CN) 2023-11-29 EP disclosed
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) 2021-03-18 US disclosed
EP-3792259-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME Changchun Hyperions Technology Co., Ltd. (CN) 2021-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SOX18, TYR, L1CAM KDM4E 148/4885MEN1 3847/4885LMNA 809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.